Kartik Doshi
About Kartik Doshi
Kartik Doshi is a Manager in Field Medical Science at Bristol-Myers Squibb, specializing in immuno-oncology with extensive experience in oncology and clinical trials.
Current Role at Bristol-Myers Squibb
Kartik Doshi is currently employed as a Manager in Field Medical Science at Bristol-Myers Squibb. He operates out of Mumbai, Maharashtra, India. His role includes specializing in immuno-oncology, where he leverages his extensive background in oncology and clinical trials to contribute to the advancement of cancer treatments.
Previous Position at Abbott Healthcare
Before joining Bristol-Myers Squibb, Kartik Doshi served as a Medical Advisor in Oncology at Abbott Healthcare. He worked in this capacity from 2015 to 2018 in the Mumbai Area, India. His role primarily involved advising on various oncology-related medical matters and fostering advancements in cancer treatment and research.
Experience at Tata Memorial Centre
Kartik Doshi has also worked at the Tata Memorial Centre (Advanced Centre for Treatment, Research and Education in Cancer) as a Clinical Pharmacologist. He was employed there from 2013 to 2015. During this time, he focused on the pharmacological aspects of cancer treatment, contributing to the center's extensive research in oncology.
Academic Background and Medical Education
Kartik Doshi holds a Doctor of Medicine (M.D.) in Pharmacology from CMC Ludhiana, Punjab, India, obtained between 2010 to 2013. He also holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from The Maharaja Sayajirao University of Baroda, earned from 2002 to 2008. His academic achievements laid a strong foundation for his specialized work in oncology and pharmacology.
Expertise in Oncology and Clinical Trials
Throughout his career, Kartik Doshi has built strong expertise in oncology, particularly focusing on cancer treatment and research. He is adept in conducting and overseeing clinical trials, making significant contributions to pharmaceutical research. His work predominantly revolves around improving cancer treatments through rigorous scientific research and clinical applications.